Association of Tocolytic Therapy with Antenatal Steroid Administration and Infant Outcomes

Mari Palta; Mona Sadek; Tjen-Sien Lim; Michael Evans; Gail McGuinness; null Newborn Lung Project

doi:10.1055/s-2007-993904

American Journal of Perinatology, Table of Contents

Am J Perinatol 1998; 15(2): 87-92
DOI: 10.1055/s-2007-993904

ORIGINAL ARTICLE

Association of Tocolytic Therapy with Antenatal Steroid Administration and Infant Outcomes

Mari Palta¹ , Mona Sadek¹ , Tjen-Sien Lim² , Michael Evans¹ , Gail McGuinness³ , Newborn Lung Project[4]

¹Department of Preventive Medicine, University of Wisconsin, Madison, Wisconsin
²Department of Statistics, University of Wisconsin, Madison, Wisconsin
³Department of Pediatrics, University of Iowa, Iowa City, Iowa

Abstract

ABSTRACT

The use of tocolytic agents to halt premature labor is controversial. We examine a database on very low-birth-weight infants born following the onset of premature labor (n = 540) for association between tocolytic and antenatal steroid therapy, and to assess neonatal and childhood outcomes following combined therapy. Data are from a multi-center regionally based study of all infants below 1501 g at seven neonatal intensive care units (NICUs) in Wisconsin and Iowa, born August 1, 1988 through June 30, 1991. Infant outcomes analyzed are death in the first 30 days, respiratory distress syndrome (RDS), and intraventricular hemorrhage (IVH). Fewer deliveries occurred within 12 hours of labor onset with tocolytics (61 vs. 75% without). A strong association between tocolytic therapy and antenatal steroid administration was found [adjusted odds ratio OR = 5.7, 95% confidence interval Cl: (3.3, 10.0)]. Tocolytics were associated with lower mortality in the first 30 days [OR = 0.29, Cl: (0.15, 0.56)]. Joint administration of tocolytics and antenatal steroids versus neither was associated with lower incidence of the combined outcome of respiratory distress syndrome (RDS) or death [OR = .30, Cl: (0.15, 0.60)] and grade III-IV IVH or death [OR = 0.35, Cl: (0.14, 0.98)]. Tocolytic therapy alone was not associated with IVH grade III-IV [OR = 1.0, Cl: (0.57, 1.9)] among survivors.

Keywords

Tocolytics - corticosteroids - neonatal outcomes

Full Text

References

4 The Newborn Lung Project presently involves the following investigators, project and center coordinators: Mari Palta, Ph.D., Principal Investigator; Mona Sadek, M.B.B.Ch., Project Coordinator; Christina Iyama, M.D. (all University of Wisconsin, Madison); Nan Peterson, R.N., M.S., Meriter-Madison General Hospital Madison, WI and University of Wisconsin G.C.R.C.; Paul Myers, M.D., Cindy Wierichs R.N., Pamela Verhagen, R.N., Theda Clark Hospital Neenah, W.I.; Gail McGuinness, M.D., Irma Kromer, B.S., University of Iowa, Iowa City, IA; James Opitz, M.D., Joan Filbin, R.N.C., St. Joseph's Hospital Marshfield, WI; David Samuels, M.D., Sue Vollmer, R.N.C., N.N.P., Lana Reinke, R.N., Ruth Rodda, R.N., St. Vincent Hospital Green Bay, WI; Marie Weinstein, M.D., Laura Ziebarth, R.N., St. Mary's Hospital Madison, WI.